Author:
Yates J.,Choudhry M.,Keys G.
Subject
Pharmacology (medical),Pharmacology
Reference13 articles.
1. National Institute for Health and Clinical Excellence 2009 Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults http://www.nice.org.uk/nicemedia/pdf/TA170Guidance.pdf
2. Bayer HealthCare AG 2011 Xarelto® (rivaroxaban) Summary of Product Characteristics as approved by the European Commission http://www.xarelto.com/html/downloads/Xalrelto_summary_of_product_characteristics_Jan2011.pdf
3. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty;Eriksson;N Engl J Med,2008
4. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial;Kakkar;Lancet,2008
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献